Position in DXCM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,901,425
+$226,926 QoQ
Shares Held
28,232
+5.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#393
of 966 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026J. Stern & Co. LLP holds $30,142,344 across 2 Medical Devices names. DXCM ranks #2 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
311,229 | $28,240,919 | |
| 2 | DXCM |
Dexcom Inc
This page
|
28,232 | $1,901,425 |
All Filings in DXCM
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,901,425 | 28,232 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,674,499 | 26,664 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,601,972 | 24,137 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $4,867,220 | 72,332 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,495,789 | 40,048 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,572,894 | 37,676 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,148,396 | 27,625 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,571,283 | 23,438 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,233,687 | 10,881 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $344,946 | 2,487 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $166,528 | 1,342 | Shares | Sole | 2024-02-22 | |
| No filing history on record for this holder in this stock. | ||||||